Nina Maouelainin, DO, FCCP, MBA
@lungsolutions
Interventional Pulmonologist #WiIP #PhysicianRise #thewhiteribbonproject Founder&President of Lung Health Services/Mother/Speaker/Tweets r my own
ID: 319291692
http://lunghealthservices.com 17-06-2011 21:40:56
10,10K Tweet
1,1K Takipçi
2,2K Takip Edilen
#ESMO25 Update on Beamion LUNG-1 study of zongertinib, focused on first-line cohort from Sanjay Popat. Zongertinib is a HER2 specific, EGFR sparing TKI FDA approved for previously treated #HER2 mutant NSCLC. Here, cohort 2: TKD mutant, treatment naive. #ESMOAmbassadors
#ESMO25 Dr. Melissa L. Johnson updates PHAROS: encorafenib + binimetinib in #BRAF V600E NSCLC. 1L RR 75%, DOR 40m (!), PFS 30.4m, OS 47.6m. Later line RR 49%, DOR 16.7m, PFS 9.3m, OS 22.7m. Pyrexia in only 8%, main toxicities nausea, diarrhea. Impressive update! #ESMOAmbassadors
I’m filled with joy to see my mentor and friend land his 2nd NEJM article after a 20+ year journey defining how to prognosticate PSA relapse and guiding Astellas Pharma US to design a trial that worked and improved survival. Congrats Steve! Stephen Freedland, MD
A wonderful #ESMO25 with practice changing data - 50 years of progress, 50 years of community with ESMO - Eur. Oncology, people from around the world unified in a common goal against cancer. #ESMOAmbassadors #myESMOstory
Fantastic, thoughtful discussion between Oncology Brothers & Eric K. Singhi, MD about 1st line treatment options for #EGFR #NSCLC. Having options that have significant OS benefits is amazing, but all regimens have toxicities. Every lung #onc should not just prescribe treatment, but also
Join us for the Chen-Huang Center’s Fifth Annual Patient & Caregiver Forum 🗓 Monday, November 17 | ⏰ 6–8 PM ET | Zoom Join to hear from experts and advocates in the lung cancer community. Register: tinyurl.com/2025egfrforum 📧 Questions? Email- [email protected]
Hope. Innovation. Collaboration. In the latest #LungCancerConsidered, Narjust Florez, MD, FASCO chats with Ann Steagall & Amanda Nerstad about the 2025 Lung Cancer Hope Summit. Tune in now: bit.ly/42Qj226 LUNGevity Foundation
Data from the Dutch cancer Registry on survival in patients with NSCLC and leptomeningeal metastases Lung Cancer Journal from Lizza Hendriks group. OS with best supportive care 1.3m, with chemo +/- IO ~8m, with targeted therapy 20.5m. Importance of testing. lungcancerjournal.info/article/S0169-…